<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T10:19:55Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6220552" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6220552</identifier>
        <datestamp>2018-11-15</datestamp>
        <setSpec>jaha</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id>
              <journal-id journal-id-type="publisher-id">JAH3</journal-id>
              <journal-id journal-id-type="hwp">ahaoa</journal-id>
              <journal-title-group>
                <journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2047-9980</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6220552</article-id>
              <article-id pub-id-type="pmcid">PMC6220552</article-id>
              <article-id pub-id-type="pmc-uid">6220552</article-id>
              <article-id pub-id-type="pmid">29895590</article-id>
              <article-id pub-id-type="pmid">29895590</article-id>
              <article-id pub-id-type="doi">10.1161/JAHA.118.009151</article-id>
              <article-id pub-id-type="publisher-id">JAH33236</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Hypertension</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success</article-title>
                <alt-title alt-title-type="left-running-head">Saxena etÂ al</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jah33236-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Saxena</surname>
                    <given-names>Manish</given-names>
                  </name>
                  <degrees>MBBS, MSc</degrees>
                  <address>
                    <email>m.saxena@qmul.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="jah33236-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0002" contrib-type="author">
                  <name>
                    <surname>Shour</surname>
                    <given-names>Tariq</given-names>
                  </name>
                  <degrees>BSc</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0003" contrib-type="author">
                  <name>
                    <surname>Shah</surname>
                    <given-names>Mussadiq</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0004" contrib-type="author">
                  <name>
                    <surname>Wolff</surname>
                    <given-names>Christopher B.</given-names>
                  </name>
                  <degrees>MBBS, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0005" contrib-type="author">
                  <name>
                    <surname>Julu</surname>
                    <given-names>Peter O. O.</given-names>
                  </name>
                  <degrees>MBChB, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0006" contrib-type="author">
                  <name>
                    <surname>Kapil</surname>
                    <given-names>Vikas</given-names>
                  </name>
                  <degrees>MBBS, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0007" contrib-type="author">
                  <name>
                    <surname>Collier</surname>
                    <given-names>David J.</given-names>
                  </name>
                  <degrees>MBBS, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0008" contrib-type="author">
                  <name>
                    <surname>Ng</surname>
                    <given-names>Fu Liang</given-names>
                  </name>
                  <degrees>MBBS, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0009" contrib-type="author">
                  <name>
                    <surname>Gupta</surname>
                    <given-names>Ajay</given-names>
                  </name>
                  <degrees>MBBS, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0010" contrib-type="author">
                  <name>
                    <surname>Balawon</surname>
                    <given-names>Armida</given-names>
                  </name>
                  <degrees>MBBS</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0011" contrib-type="author">
                  <name>
                    <surname>Pheby</surname>
                    <given-names>Jane</given-names>
                  </name>
                  <degrees>BSc</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0012" contrib-type="author">
                  <name>
                    <surname>Zak</surname>
                    <given-names>Anne</given-names>
                  </name>
                  <degrees>BSc</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0013" contrib-type="author">
                  <name>
                    <surname>Rull</surname>
                    <given-names>Gurvinder</given-names>
                  </name>
                  <degrees>MBBS, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0014" contrib-type="author">
                  <name>
                    <surname>O'Brien</surname>
                    <given-names>Benjamin</given-names>
                  </name>
                  <degrees>MBBS, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0015" contrib-type="author">
                  <name>
                    <surname>Schmieder</surname>
                    <given-names>Roland E.</given-names>
                  </name>
                  <degrees>MBBS, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah33236-cr-0016" contrib-type="author">
                  <name>
                    <surname>Lobo</surname>
                    <given-names>Melvin D.</given-names>
                  </name>
                  <degrees>MBChB, PhD</degrees>
                  <xref ref-type="aff" rid="jah33236-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="jah33236-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="jah33236-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Barts BP Centre of Excellence</named-content>
                <named-content content-type="organisation-division">Barts Heart Centre</named-content>
                <institution>St Bartholomew's Hospital</institution>
                <named-content content-type="city">London</named-content>
                <country country="GB">United Kingdom</country>
              </aff>
              <aff id="jah33236-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">William Harvey Research Institute</named-content>
                <named-content content-type="organisation-division">Centre for Clinical Pharmacology</named-content>
                <named-content content-type="organisation-division">Barts NIHR Cardiovascular Biomedical Research Unit</named-content>
                <institution>Queen Mary University London</institution>
                <named-content content-type="city">London</named-content>
                <country country="GB">United Kingdom</country>
              </aff>
              <aff id="jah33236-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Department of Nephrology and Hypertension</named-content>
                <named-content content-type="organisation-division">University Hospital</named-content>
                <institution>University of Erlangen/Nuremberg</institution>
                <named-content content-type="city">Erlangen</named-content>
                <country country="DE">Germany</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence to:</bold> Manish Saxena, MBBS, MSc, William Harvey Research Institute, Charterhouse Square, London, PO O/S17, EC1M 6BQ, United Kingdom. Eâmail: <email>m.saxena@qmul.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>12</day>
                <month>6</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="collection">
                <day>19</day>
                <month>6</month>
                <year>2018</year>
              </pub-date>
              <volume>7</volume>
              <issue>12</issue>
              <issue-id pub-id-type="doi">10.1002/jah3.2018.7.issue-12</issue-id>
              <elocation-id>e009151</elocation-id>
              <history>
                <date date-type="received">
                  <day>11</day>
                  <month>3</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>28</day>
                  <month>4</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell <copyright-statement>-->
                <copyright-statement content-type="article-copyright">Â© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement>
                <license license-type="creativeCommonsBy">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JAH3-7-e009151.pdf"/>
              <abstract id="jah33236-abs-0001">
                <sec id="jah33236-sec-0001">
                  <title>Background</title>
                  <p>Renal denervation has no validated marker of procedural success. We hypothesized that successful renal denervation would reduce renal sympathetic nerve signaling demonstrated by attenuation of Î±â1âadrenoceptorâmediated autotransfusion during the Valsalva maneuver.</p>
                </sec>
                <sec id="jah33236-sec-0002">
                  <title>Methods and Results</title>
                  <p>In this substudy of the Wave IV Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension, we enrolled 23 subjects with resistant hypertension. They were randomized either to bilateral renal denervation using therapeutic levels of ultrasound energy (n=12) or sham application of diagnostic ultrasound (n=11). Withinâgroup changes in autonomic parameters, office and ambulatory blood pressure were compared between baseline and 6Â months in a doubleâblind manner. There was significant office blood pressure reduction in both treatment (16.1Â±27.3Â mmÂ Hg, <italic>P</italic>&lt;0.05) and sham groups (27.9Â±15.0Â mmÂ Hg, <italic>P</italic>&lt;0.01) because of which the study was discontinued prematurely. However, during the late phase <styled-content style="fixed-case">II</styled-content> (Iii) of Valsalva maneuver, renal denervation resulted in substantial and significant reduction in mean arterial pressure (21.8Â±25.2Â mmÂ Hg, <italic>P</italic>&lt;0.05) with no significant changes in the sham group. Moreover, there were significant reductions in heart rate in the actively treated group at rest (6.0Â±11.5Â beats per minute, <italic>P</italic>&lt;0.05) and during postural changes (supine 7.2Â±8.4Â beats per minute, <italic>P</italic>&lt;0.05, sit up 12.7Â±16.7Â beats per minute, <italic>P</italic>&lt;0.05), which were not observed in the sham group.</p>
                </sec>
                <sec id="jah33236-sec-0003">
                  <title>Conclusions</title>
                  <p>Blood pressure reduction per se is not necessarily a marker of successful renal nerve ablation. Reduction in splanchnic autotransfusion following renal denervation has not been previously demonstrated and denotes attenuation of (renal) sympathetic efferent activity and could serve as a marker of procedural success.</p>
                </sec>
                <sec id="jah33236-sec-0004">
                  <title>Clinical Trial Registration</title>
                  <p><styled-content style="fixed-case">URL</styled-content>: <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov">https://www.clinicaltrials.gov</ext-link>. Unique identifier: <styled-content style="fixed-case">NCT</styled-content>02029885.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jah33236-kwd-0001">autonomic function</kwd>
                <kwd id="jah33236-kwd-0002">blood pressure</kwd>
                <kwd id="jah33236-kwd-0003">hypertension</kwd>
                <kwd id="jah33236-kwd-0004">renal denervation</kwd>
                <kwd id="jah33236-kwd-0005">sympathetic nervous system</kwd>
                <kwd id="jah33236-kwd-0006">ultrasound</kwd>
                <kwd id="jah33236-kwd-0007">Valsalva maneuver</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>High Blood Pressure</kwd>
                <kwd>Hypertension</kwd>
                <kwd>Autonomic Nervous System</kwd>
                <kwd>Clinical Studies</kwd>
                <kwd>Ultrasound</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>Kona Medical</funding-source>
                </award-group>
                <award-group>
                  <funding-source>Barts Charity</funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="0"/>
                <table-count count="3"/>
                <page-count count="8"/>
                <word-count count="6266"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>component-id</meta-name>
                  <meta-value>jah33236</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>19 June 2018</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.1.1 mode:remove_FC converted:19.06.2018</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="jah33236-cit-1001">(<source xml:lang="en">J Am Heart Assoc</source>. <year>2018</year>;<volume>7</volume>:<elocation-id>e009151</elocation-id> DOI: <pub-id pub-id-type="doi">10.1161/JAHA.118.009151</pub-id>.)<pub-id pub-id-type="pmid">29895590</pub-id></mixed-citation>
              </p>
              <fn-group id="jah33236-ntgp-0001">
                <fn id="jah33236-note-1002">
                  <p>This article was handled independently by Joseph I. Shapiro, MD as a guest editor. The editors had no role in the evaluation of the manuscript or in the decision about its acceptance.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body>
            <p>
              <boxed-text position="anchor" content-type="box" id="jah33236-blkfxd-0001" orientation="portrait">
                <sec id="jah33236-sec-0006">
                  <title>Clinical Perspective</title>
                  <sec id="jah33236-sec-0007">
                    <title>What Is New?</title>
                    <p>
                      <list list-type="bullet" id="jah33236-list-0001">
                        <list-item>
                          <p>We describe a novel strategy to evaluate the procedural success of an ultrasoundâbased renal denervation platform by use of noninvasive autonomic function testing (with realâtime beatâtoâbeat blood pressure monitoring) to delineate changes in heart rate, mean arterial pressure, and autotransfusion responses to the Valsalva maneuver.</p>
                        </list-item>
                        <list-item>
                          <p>This methodology, which is easily reproducible, offers an attractive alternative to the current approaches to assess sympathetic nervous system activity such as microneurography and norepinephrine spillover techniques.</p>
                        </list-item>
                      </list>
                    </p>
                  </sec>
                  <sec id="jah33236-sec-0008">
                    <title>What Are the Clinical Implications?</title>
                    <p>
                      <list list-type="bullet" id="jah33236-list-0002">
                        <list-item>
                          <p>We demonstrate that renal denervation resulted in significant reductions in both heart rate and autotransfusion response to the Valsalva maneuver, suggesting that external ultrasound renal denervation is effective, and that greater blood pressure reduction alone may be misleading as a sole marker of response to an interventional procedure compared with sham.</p>
                        </list-item>
                        <list-item>
                          <p>This study makes a significant contribution to the debate over the utility of the sham procedure in device therapy of hypertension trials and emphasizes the need to find noninvasive markers of procedural success of renal denervation.</p>
                        </list-item>
                      </list>
                    </p>
                  </sec>
                </sec>
              </boxed-text>
            </p>
            <sec id="jah33236-sec-0009">
              <p>The recent past has seen the emergence of a variety of promising novel nonpharmacological deviceâbased therapies for treating hypertension.<xref rid="jah33236-bib-0001" ref-type="ref">1</xref> Most of these new technologies target sympathoâmodulation either through renal nerve ablation (renal denervation or RDN) or through electrical carotid sinus stimulation (baroreflex activation therapy), although other technologies may target mechanical aspects of the circulation through the creation of a central iliac arteriovenous anastomosis.<xref rid="jah33236-bib-0002" ref-type="ref">2</xref>, <xref rid="jah33236-bib-0003" ref-type="ref">3</xref>, <xref rid="jah33236-bib-0004" ref-type="ref">4</xref>, <xref rid="jah33236-bib-0005" ref-type="ref">5</xref>, <xref rid="jah33236-bib-0006" ref-type="ref">6</xref>, <xref rid="jah33236-bib-0007" ref-type="ref">7</xref> At present, RDN has been studied the most and is thought to lower blood pressure (BP) by reducing central sympathetic drive and in turn, reducing sympathetic outflow to kidneys.<xref rid="jah33236-bib-0008" ref-type="ref">8</xref>, <xref rid="jah33236-bib-0009" ref-type="ref">9</xref>
</p>
              <p>A major concern with RDN is that there is no procedural marker of success and it is still regarded as a âblack boxâ procedure whereby the operator is unaware at the time of intervention whether or not the renal nerves have been successfully ablated.<xref rid="jah33236-bib-0010" ref-type="ref">10</xref> Recent data identifying more precisely the location of human renal sympathetic nerves have better informed the procedure to improve delivery of ablation foci in the most appropriate territory, but this still does not address whether or not the technology has achieved its intended aim of renal nerve destruction.<xref rid="jah33236-bib-0011" ref-type="ref">11</xref>
</p>
              <p>The use of physiological measures and biomarkers to confirm procedural success of renal nerve ablation, such as muscle sympathetic nerve activity and renal norepinephrine spillover, has been proposed but remains contentious.<xref rid="jah33236-bib-0012" ref-type="ref">12</xref>, <xref rid="jah33236-bib-0013" ref-type="ref">13</xref>, <xref rid="jah33236-bib-0014" ref-type="ref">14</xref> Renal nerve stimulationâinduced BP increase preâ and postâRDN has been shown to be a good marker to predict BP response and assess efficacy of RDN but requires further validation.<xref rid="jah33236-bib-0015" ref-type="ref">15</xref> Thus, there remains a pressing need to identify valid biomarkers to confirm procedural success that are noninvasive and easy to use in everyday clinical practice.</p>
              <p>The objectives of this substudy were to investigate changes in physiological and autonomic nervous system parameters with noninvasive testing in subjects with resistant hypertension randomized to having bilateral renal nerve ablation using externally delivered focused ultrasound or sham therapy. Specifically, our aim was to test the hypothesis that successful renal nerve ablation would result in attenuation of renal sympathetic nervous system (SNS) activity measured as a lowering of global sympathetic tone and also as a reduction in sympathetically mediated autotransfusion during (late) phase II of the Valsalva maneuver, which depends in part upon renal capsular contraction mediated through renal SNS signaling.<xref rid="jah33236-bib-0016" ref-type="ref">16</xref>
</p>
            </sec>
            <sec id="jah33236-sec-0010">
              <title>Methods</title>
              <p>The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.</p>
              <sec id="jah33236-sec-0011">
                <title>Study Design and Subjects</title>
                <p>This study is a singleâcenter substudy of the Wave IV Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension study, an international, multicenter, randomized, shamâcontrolled, doubleâblind clinical trial of RDN in subjects with treatmentâresistant hypertension.<xref rid="jah33236-bib-0017" ref-type="ref">17</xref> The study had approval from a Central Research Ethics Committee and all participants gave written informed consent to take part in the main study and the substudy. Subjects between 18 and 80Â years of age with uncontrolled primary arterial hypertension, defined as office SBP â¥160Â mmÂ Hg while taking 3 or more antihypertensive medications at the maximally tolerated doses, one of which was a diuretic, were enrolled in the study. Other inclusion criteria were a 24âhour ambulatory BP monitoring average SBP of â¥135Â mmÂ Hg and no medication changes within the month before baseline. Subjects were excluded from the study if they had a secondary cause of hypertension; had clinically significant renal artery stenosis; had previously undergone RDN; had known severe pulmonary hypertension; had experienced a myocardial infarction, unstable angina, or cerebrovascular event within the 6Â months before baseline; had hemodynamically significant valvular heart disease; had a body mass index (BMI) &gt;35Â kg/m<sup>2</sup>; or were pregnant, nursing, or intended to become pregnant during the study period. Furthermore, factors that may preclude clear visualization of the renal parenchyma and renal artery were also exclusion criteria.</p>
                <p>Patients were centrally randomized in a 1:1 ratio to receive either the active RDN treatment or the sham control, both administered using the Surround Sound System. The treatment consisted of bilateral RDN using therapeutic levels of ultrasound energy. The sham consisted of bilateral sham treatment using diagnostic levels of ultrasound energy. A detailed description of the study design and interventional/sham procedures can be found in Data <xref rid="jah33236-sup-0001" ref-type="supplementary-material">S1</xref>.</p>
              </sec>
              <sec id="jah33236-sec-0012">
                <title>Office BP</title>
                <p>The office BP measurements were recorded with an automated validated Omron M6 Comfort Intellisense device (Omron Corp, Tokyo, Japan) in triplicate, taken with subjects in a seated position, after 10Â minutes of rest. The 3 BP measurements were taken 1Â minute apart and the average of the 3 measurements was calculated.</p>
                <p>At the screening visit, BP was measured in triplicate in both arms and the arm with the highest BP was used for all subsequent readings for the entire duration of the study. At any visit, if the variability in the 3 BP readings was &gt;15Â mmÂ Hg, another set of 3 readings was taken.</p>
              </sec>
              <sec id="jah33236-sec-0013">
                <title>Ambulatory BP</title>
                <p>Ambulatory BP was measured using oscillometric Space Labs 90207â1Q monitor (Spacelabs Healthcare, Hertford, UK). BP was recorded every 30Â minutes during the daytime and every 60Â minutes during the night. Technical success of the ambulatory BP monitoring required 70% of BP recordings to be valid.</p>
              </sec>
              <sec id="jah33236-sec-0014">
                <title>Autonomic Function Tests</title>
                <p>Autonomic function tests were conducted in a standardized controlled environment with a room temperature of 23Â±1Â°C, diffused lighting, and no background noise. The procedure was discussed in detail with the subjects beforehand so that they were well familiar with the autonomic study protocol. They were relaxed and comfortable during the procedure.</p>
                <p>The ECG used to derive cardiovascular indices was recorded via 3 chest electrodes conforming to Einthoven's Lead II configuration. Noninvasive arterial BP waveform was recorded continuously using volumeâclamp photoplethysmography through a finger cuff, which is part of the Finapresâ¢ system (Finapres Medical Systems, Amsterdam, The Netherlands).<xref rid="jah33236-bib-0018" ref-type="ref">18</xref> All raw data including BP waveforms were used to derive realâtime autonomic indices by a NeuroScope using the VaguSoftâ¢ software (Medifit Instruments Ltd, London, UK). The instantaneous heart rate (HR, in beats per minute [bpm]) was calculated continuously in realâtime from the intervals between consecutive electrocardiographic Râwaves (RâR intervals) to facilitate measurement of sudden or rapid changes in HR.</p>
              </sec>
              <sec id="jah33236-sec-0015">
                <title>Postural Studies</title>
                <p>Baseline autonomic status was recorded with subjects in a reclined position (patient at 45 degrees) and subsequently supine position for at least 3Â minutes with the mean BP varying by &lt;5Â mmÂ Hg.</p>
                <p>Subjects then sat upright from the supine position with neck and legs held in a straight position while looking directly ahead, for a duration of 3Â minutes. This invokes the isometric contraction of neck and trunk muscles. At the end of sitâup, subjects returned to a reclined and supported position.</p>
              </sec>
              <sec id="jah33236-sec-0016">
                <title>Valsalva Maneuver</title>
                <p>Subjects sat on a chair, leaning forward onto an examination couch with both hands rested. This posture is designed to exert mild pressure on the femoral and iliac veins and restrict the venous return from the lower limbs. The Valsalva test assembly consists of an air pressure gauge and detachable paper mouthpiece (a vitalograph tube). The mouthpiece has an aperture at the bottom of the tube to permit a small amount of air to escape, allowing constant pressure to be maintained.</p>
                <p>Subjects blew into the tube assembly by either placing the lips tightly around the mouthpiece or squeezing the lips inside the mouthpiece. Both methods sealedâoff air leakage while blowing into the mouthpiece.</p>
                <p>After successful practices, subjects were observed at rest to ensure that mean arterial BP (MAP) was varying by &lt;5Â mmÂ Hg to make sure that subjects were relaxed and had recovered from the previous practice maneuver. To start the maneuver, subjects took a deep breath and then blew into the mouthpiece without air leaks to bring the pointer aligned with the black line in middle of the slave meter (denoting 40Â mmÂ Hg) for 15Â s. At the end of the 15Â s, the subjects stopped blowing into the mouthpiece, and resumed normal breathing at their normal tidal volume.</p>
                <p>This maneuver was repeated to obtain 3 clear recordings. The Stable segment of MAP for 20 RâR intervals just preceding the Valsalva maneuver was compared with the 4 phases and 5 peaks of the Valsalva maneuver. The best of 3 wellâperformed maneuvers with all 4 phases of BP changes was chosen for analysis.</p>
              </sec>
              <sec id="jah33236-sec-0017">
                <title>FollowâUp</title>
                <p>Subjects were assessed at baseline and 6Â months postâtreatment. At these visits, office BP measurements were recorded as described above. During the 6âmonth visit, a 24âhour ambulatory BP monitoring was repeated, together with the same battery of autonomic function tests described above. At this time point, both subjects and the study team were still blinded to the intervention allocated to individual subjects.</p>
              </sec>
              <sec id="jah33236-sec-0018">
                <title>Statistical Analysis</title>
                <p>To determine significant differences between groups, 2âtailed independent Student <italic>t</italic> tests were used. Data are represented as meanÂ±SD, unless otherwise indicated. When looking at withinâgroup differences between time points, 2âtailed dependent Student <italic>t</italic> tests were used. A significant difference was defined as having a <italic>P</italic>&lt;0.05.</p>
                <p>All authors had access to the study data and take full responsibility for its integrity and data analysis.</p>
              </sec>
            </sec>
            <sec id="jah33236-sec-0019">
              <title>Results</title>
              <sec id="jah33236-sec-0020">
                <title>Demographics</title>
                <p>The demographics of the study cohort are summarized in TableÂ <xref rid="jah33236-tbl-0001" ref-type="table">1</xref>. Out of the 23 subjects analyzed, 2 were excluded from the autonomic function analysis. One patient was lost to followâup and another did not undergo autonomic function testing before treatment. There were no statistical differences between the groups with regard to sex, age, body mass index, smoking status, comorbidities of type 2 diabetes mellitus and cardiovascular disease, and antihypertensive medications prescribed.</p>
                <table-wrap id="jah33236-tbl-0001" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Demographics</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1"/>
                        <th align="left" valign="top" rowspan="1" colspan="1">Treatment</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Sham</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Total</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">N</td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">11</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Male</td>
                        <td align="left" rowspan="1" colspan="1">9</td>
                        <td align="left" rowspan="1" colspan="1">6</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Female</td>
                        <td align="left" rowspan="1" colspan="1">3</td>
                        <td align="left" rowspan="1" colspan="1">5</td>
                        <td align="left" rowspan="1" colspan="1">8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Average age (y)</td>
                        <td align="left" rowspan="1" colspan="1">57.2Â±10.3</td>
                        <td align="left" rowspan="1" colspan="1">61.9Â±10.6</td>
                        <td align="left" rowspan="1" colspan="1">59.5Â±10.5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Average BMI</td>
                        <td align="left" rowspan="1" colspan="1">31.7Â±3.4</td>
                        <td align="left" rowspan="1" colspan="1">29.7Â±4.8</td>
                        <td align="left" rowspan="1" colspan="1">30.7Â±4.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Smoking history</td>
                        <td align="left" rowspan="1" colspan="1">6</td>
                        <td align="left" rowspan="1" colspan="1">4</td>
                        <td align="left" rowspan="1" colspan="1">10</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Type 2 DM</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">3</td>
                        <td align="left" rowspan="1" colspan="1">4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">CVD</td>
                        <td align="left" rowspan="1" colspan="1">4</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">5</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Average BP medications</td>
                        <td align="left" rowspan="1" colspan="1">4.7Â±1.5</td>
                        <td align="left" rowspan="1" colspan="1">4.7Â±1.2</td>
                        <td align="left" rowspan="1" colspan="1">4.7Â±1.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">ACEI/ARB</td>
                        <td align="left" rowspan="1" colspan="1">11</td>
                        <td align="left" rowspan="1" colspan="1">9</td>
                        <td align="left" rowspan="1" colspan="1">20</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">CCB</td>
                        <td align="left" rowspan="1" colspan="1">10</td>
                        <td align="left" rowspan="1" colspan="1">8</td>
                        <td align="left" rowspan="1" colspan="1">18</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Diuretics</td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">11</td>
                        <td align="left" rowspan="1" colspan="1">23</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Î²âBlockers</td>
                        <td align="left" rowspan="1" colspan="1">4</td>
                        <td align="left" rowspan="1" colspan="1">6</td>
                        <td align="left" rowspan="1" colspan="1">10</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Î±âBlockers</td>
                        <td align="left" rowspan="1" colspan="1">8</td>
                        <td align="left" rowspan="1" colspan="1">7</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">MR antagonist</td>
                        <td align="left" rowspan="1" colspan="1">6</td>
                        <td align="left" rowspan="1" colspan="1">5</td>
                        <td align="left" rowspan="1" colspan="1">11</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jah33236-note-0003">
                      <p>Data are expressed as meanÂ±SD. ACEI indicates angiotensinâconverting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; BP, blood pressure; CCB, calcium channel blocker; CVD, cardiovascular disease; DM, diabetes mellitus; MR, mineralocorticoid receptor.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="jah33236-sec-0021">
                <title>Office Blood Pressure</title>
                <p>The office BP data are summarized in TableÂ <xref rid="jah33236-tbl-0002" ref-type="table">2</xref>. There was a significant reduction in office SBP in both the treatment (16.1Â±27.3Â mmÂ Hg, <italic>P</italic>&lt;0.05) and sham groups (27.9Â±15.0Â mmÂ Hg, <italic>P</italic>&lt;0.001) and a significant reduction in office diastolic BP in only the sham group (15.4Â±14.9Â mmÂ Hg, <italic>P</italic>&lt;0.05), but no statistical significance between the groups.</p>
                <table-wrap id="jah33236-tbl-0002" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Changes in Office Blood Pressure and Ambulatory Blood Pressure Between Baseline and 6Â Months Postprocedure</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="top" colspan="1"/>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Treatment (n=12)</th>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Sham (n=11)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Baseline</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">6Â Mo</th>
                        <th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Baseline</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">6Â Mo</th>
                        <th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">Office</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SBP</td>
                        <td align="left" rowspan="1" colspan="1">170.7Â±11.2</td>
                        <td align="left" rowspan="1" colspan="1">154.7Â±26.9</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                        <td align="left" rowspan="1" colspan="1">180.4Â±14.3</td>
                        <td align="left" rowspan="1" colspan="1">152.4Â±25.7</td>
                        <td align="left" rowspan="1" colspan="1">0.001</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">DBP</td>
                        <td align="left" rowspan="1" colspan="1">99.9Â±14.0</td>
                        <td align="left" rowspan="1" colspan="1">91.4Â±14.8</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                        <td align="left" rowspan="1" colspan="1">101.0Â±16.8</td>
                        <td align="left" rowspan="1" colspan="1">85.7Â±14.5</td>
                        <td align="left" rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HR</td>
                        <td align="left" rowspan="1" colspan="1">78.5Â±13.0</td>
                        <td align="left" rowspan="1" colspan="1">72.5Â±11.6</td>
                        <td align="left" rowspan="1" colspan="1">0.03</td>
                        <td align="left" rowspan="1" colspan="1">76.1Â±15.8</td>
                        <td align="left" rowspan="1" colspan="1">75.2Â±17.1</td>
                        <td align="left" rowspan="1" colspan="1">0.94</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">Ambulatory</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Day SBP</td>
                        <td align="left" rowspan="1" colspan="1">157.7Â±9.5</td>
                        <td align="left" rowspan="1" colspan="1">147.1Â±17.9</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                        <td align="left" rowspan="1" colspan="1">162.8Â±5.6</td>
                        <td align="left" rowspan="1" colspan="1">152.0Â±13.5</td>
                        <td align="left" rowspan="1" colspan="1">0.01</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Day DBP</td>
                        <td align="left" rowspan="1" colspan="1">93.6Â±11.9</td>
                        <td align="left" rowspan="1" colspan="1">85.5Â±14.0</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                        <td align="left" rowspan="1" colspan="1">90.9Â±14.5</td>
                        <td align="left" rowspan="1" colspan="1">84.5Â±10.9</td>
                        <td align="left" rowspan="1" colspan="1">0.03</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Day MAP</td>
                        <td align="left" rowspan="1" colspan="1">116.3Â±8.2</td>
                        <td align="left" rowspan="1" colspan="1">107.6Â±13.8</td>
                        <td align="left" rowspan="1" colspan="1">0.08</td>
                        <td align="left" rowspan="1" colspan="1">116.0Â±8.9</td>
                        <td align="left" rowspan="1" colspan="1">108.2Â±9.0</td>
                        <td align="left" rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Day HR</td>
                        <td align="left" rowspan="1" colspan="1">76.4Â±8.1</td>
                        <td align="left" rowspan="1" colspan="1">72.1Â±6.0</td>
                        <td align="left" rowspan="1" colspan="1">0.05</td>
                        <td align="left" rowspan="1" colspan="1">75.4Â±13.9</td>
                        <td align="left" rowspan="1" colspan="1">75.9Â±15.0</td>
                        <td align="left" rowspan="1" colspan="1">0.80</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Night SBP</td>
                        <td align="left" rowspan="1" colspan="1">146.8Â±14.2</td>
                        <td align="left" rowspan="1" colspan="1">141.8Â±19.7</td>
                        <td align="left" rowspan="1" colspan="1">0.30</td>
                        <td align="left" rowspan="1" colspan="1">153.8Â±12.4</td>
                        <td align="left" rowspan="1" colspan="1">141.9Â±20.2</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Night DBP</td>
                        <td align="left" rowspan="1" colspan="1">82.8Â±11.0</td>
                        <td align="left" rowspan="1" colspan="1">81.0Â±14.7</td>
                        <td align="left" rowspan="1" colspan="1">0.61</td>
                        <td align="left" rowspan="1" colspan="1">83.8Â±12.3</td>
                        <td align="left" rowspan="1" colspan="1">76.5Â±12.3</td>
                        <td align="left" rowspan="1" colspan="1">0.05</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Night MAP</td>
                        <td align="left" rowspan="1" colspan="1">105.9Â±10.6</td>
                        <td align="left" rowspan="1" colspan="1">102.6Â±14.8</td>
                        <td align="left" rowspan="1" colspan="1">0.40</td>
                        <td align="left" rowspan="1" colspan="1">109.0Â±8.9</td>
                        <td align="left" rowspan="1" colspan="1">99.6Â±12.5</td>
                        <td align="left" rowspan="1" colspan="1">0.02</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Night HR</td>
                        <td align="left" rowspan="1" colspan="1">69.9Â±7.8</td>
                        <td align="left" rowspan="1" colspan="1">68Â±7.9</td>
                        <td align="left" rowspan="1" colspan="1">0.44</td>
                        <td align="left" rowspan="1" colspan="1">70.4Â±10.2</td>
                        <td align="left" rowspan="1" colspan="1">71.2Â±13.5</td>
                        <td align="left" rowspan="1" colspan="1">0.73</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jah33236-note-0004">
                      <p>Data are expressed as meanÂ±SD. <italic>P</italic> values compares the 2 time points. DBP indicates diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; SBP, systolic blood pressure.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="jah33236-sec-0022">
                <title>Ambulatory Blood Pressure</title>
                <p>In the treatment group, reductions in daytime SBP, diastolic BP, and MAP were numerically similar to the sham group butÂ did not achieve statistical significance. In the sham limb,Â there was a significant reduction in daytime SBP (10.8Â±12.0Â mmÂ Hg, <italic>P</italic>&lt;0.05), daytime diastolic BP (6.5Â±8.6Â mmÂ Hg, <italic>P</italic>&lt;0.05), daytime mean arterial pressure (MAP) (7.8Â±9.7Â mmÂ Hg, <italic>P</italic>&lt;0.05), nightâtime SBP (11.9Â±16.3Â mmÂ Hg, <italic>P</italic>&lt;0.05), and nightâtime MAP (9.4Â±11.3Â mmÂ Hg, <italic>P</italic>&lt;0.05). There were no statistical differences between the treatment and sham groups. The 24âhour ambulatory BP data are summarized in TableÂ <xref rid="jah33236-tbl-0002" ref-type="table">2</xref>.</p>
              </sec>
              <sec id="jah33236-sec-0023">
                <title>Heart Rate</title>
                <p>There was a significant reduction in resting HR in only the treatment group (6.0Â±11.5Â bpm, <italic>P</italic>&lt;0.05) compared with baseline. In the treatment limb, significant reduction was observed in the daytime HR (4.3Â±6.6Â bpm <italic>P</italic>&lt;0.05) during 24âhour BP monitoring with no significant HR changes in the sham group during day or night. The office and 24âhour HR data are summarized in TableÂ <xref rid="jah33236-tbl-0002" ref-type="table">2</xref>.</p>
              </sec>
              <sec id="jah33236-sec-0024">
                <title>BP and HR responses to Autonomic Function Tests</title>
                <p>The autonomic function test results are summarized in TableÂ <xref rid="jah33236-tbl-0003" ref-type="table">3</xref>. During postural studies, there was a significant reduction in HR in the treatment group in the reclined position (6.9Â±9.1Â bpm, <italic>P</italic>&lt;0.05) and supine position (7.2Â±8.4Â bpm, <italic>P</italic>&lt;0.05) following RDN (TableÂ <xref rid="jah33236-tbl-0003" ref-type="table">3</xref>). There was no statistical difference between the treatment and sham groups in the change over time. There was also a significant reduction in both HR (12.7Â±16.7Â bpm, <italic>P</italic>&lt;0.05) and MAP during the sit up (10.6Â±13.7Â mmÂ Hg, <italic>P</italic>&lt;0.05) at 6Â months followâup compared with baseline. No statistically significant changes were identified in the sham group.</p>
                <table-wrap id="jah33236-tbl-0003" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 3</label>
                  <caption>
                    <p>Changes With Autonomic Function Tests Between Baseline and 6Â Months Postprocedure</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="top" colspan="1"/>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Treatment (n=10)</th>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Sham (n=11)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Baseline</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">6Â Mo</th>
                        <th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">Baseline</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">6Â Mo</th>
                        <th align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic> Value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">Postural studies</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SBP reclined</td>
                        <td align="left" rowspan="1" colspan="1">153.5Â±22.6</td>
                        <td align="left" rowspan="1" colspan="1">137.0Â±29.1</td>
                        <td align="left" rowspan="1" colspan="1">0.18</td>
                        <td align="left" rowspan="1" colspan="1">158.0Â±18.9</td>
                        <td align="left" rowspan="1" colspan="1">152.0Â±38.1</td>
                        <td align="left" rowspan="1" colspan="1">0.50</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">DBP reclined</td>
                        <td align="left" rowspan="1" colspan="1">70.8Â±20.9</td>
                        <td align="left" rowspan="1" colspan="1">62.2Â±19.4</td>
                        <td align="left" rowspan="1" colspan="1">0.14</td>
                        <td align="left" rowspan="1" colspan="1">65.0Â±18.7</td>
                        <td align="left" rowspan="1" colspan="1">63.8Â±21.1</td>
                        <td align="left" rowspan="1" colspan="1">0.77</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">MAP reclined</td>
                        <td align="left" rowspan="1" colspan="1">98.3Â±19.9</td>
                        <td align="left" rowspan="1" colspan="1">87.1Â±21.5</td>
                        <td align="left" rowspan="1" colspan="1">0.15</td>
                        <td align="left" rowspan="1" colspan="1">96.0Â±14.0</td>
                        <td align="left" rowspan="1" colspan="1">93.2Â±20.8</td>
                        <td align="left" rowspan="1" colspan="1">0.58</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HR reclined</td>
                        <td align="left" rowspan="1" colspan="1">79.6Â±14.7</td>
                        <td align="left" rowspan="1" colspan="1">70.5Â±13.8</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                        <td align="left" rowspan="1" colspan="1">71.3Â±13.2</td>
                        <td align="left" rowspan="1" colspan="1">72.1Â±13.1</td>
                        <td align="left" rowspan="1" colspan="1">0.81</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SBP supine</td>
                        <td align="left" rowspan="1" colspan="1">148.4Â±21.7</td>
                        <td align="left" rowspan="1" colspan="1">136.4Â±28.3</td>
                        <td align="left" rowspan="1" colspan="1">0.29</td>
                        <td align="left" rowspan="1" colspan="1">159.4Â±21.6</td>
                        <td align="left" rowspan="1" colspan="1">156.1Â±37.1</td>
                        <td align="left" rowspan="1" colspan="1">0.72</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">DBP supine</td>
                        <td align="left" rowspan="1" colspan="1">66.1Â±20.6</td>
                        <td align="left" rowspan="1" colspan="1">59.6Â±19.2</td>
                        <td align="left" rowspan="1" colspan="1">0.26</td>
                        <td align="left" rowspan="1" colspan="1">61.0Â±18.2</td>
                        <td align="left" rowspan="1" colspan="1">59.3Â±19.8</td>
                        <td align="left" rowspan="1" colspan="1">0.67</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">MAP supine</td>
                        <td align="left" rowspan="1" colspan="1">93.5Â±19.3</td>
                        <td align="left" rowspan="1" colspan="1">85.2Â±21.0</td>
                        <td align="left" rowspan="1" colspan="1">0.26</td>
                        <td align="left" rowspan="1" colspan="1">93.8Â±14.7</td>
                        <td align="left" rowspan="1" colspan="1">91.7Â±19.7</td>
                        <td align="left" rowspan="1" colspan="1">0.69</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HR supine</td>
                        <td align="left" rowspan="1" colspan="1">77.9Â±13.7</td>
                        <td align="left" rowspan="1" colspan="1">69.1Â±13.9</td>
                        <td align="left" rowspan="1" colspan="1">0.02</td>
                        <td align="left" rowspan="1" colspan="1">69.4Â±12.1</td>
                        <td align="left" rowspan="1" colspan="1">69.2Â±12.2</td>
                        <td align="left" rowspan="1" colspan="1">0.91</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">SBP sit up</td>
                        <td align="left" rowspan="1" colspan="1">206.5Â±21.3</td>
                        <td align="left" rowspan="1" colspan="1">190.2Â±28.2</td>
                        <td align="left" rowspan="1" colspan="1">0.05</td>
                        <td align="left" rowspan="1" colspan="1">200.7Â±27.1</td>
                        <td align="left" rowspan="1" colspan="1">176.0Â±33.3</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">DBP sit up</td>
                        <td align="left" rowspan="1" colspan="1">98.4Â±24.5</td>
                        <td align="left" rowspan="1" colspan="1">90.7Â±24.9</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                        <td align="left" rowspan="1" colspan="1">85.1Â±27.1</td>
                        <td align="left" rowspan="1" colspan="1">77.7Â±28.2</td>
                        <td align="left" rowspan="1" colspan="1">0.26</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">MAP sit up</td>
                        <td align="left" rowspan="1" colspan="1">134.1Â±21.6</td>
                        <td align="left" rowspan="1" colspan="1">123.9Â±23.9</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                        <td align="left" rowspan="1" colspan="1">124.3Â±21.4</td>
                        <td align="left" rowspan="1" colspan="1">110.4Â±24.9</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">HR sit up</td>
                        <td align="left" rowspan="1" colspan="1">101.4Â±23.8</td>
                        <td align="left" rowspan="1" colspan="1">84.9Â±17.4</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                        <td align="left" rowspan="1" colspan="1">84.1Â±15.2</td>
                        <td align="left" rowspan="1" colspan="1">83.7Â±17.8</td>
                        <td align="left" rowspan="1" colspan="1">0.86</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">Valsalva</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Valsalva base MAP</td>
                        <td align="left" rowspan="1" colspan="1">120.2Â±19.7</td>
                        <td align="left" rowspan="1" colspan="1">107.6Â±18.6</td>
                        <td align="left" rowspan="1" colspan="1">0.07</td>
                        <td align="left" rowspan="1" colspan="1">113.0Â±22.4</td>
                        <td align="left" rowspan="1" colspan="1">102.4Â±30.2</td>
                        <td align="left" rowspan="1" colspan="1">0.26</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Valsalva I MAP</td>
                        <td align="left" rowspan="1" colspan="1">146.8Â±22.0</td>
                        <td align="left" rowspan="1" colspan="1">126.6Â±22.0</td>
                        <td align="left" rowspan="1" colspan="1">0.03</td>
                        <td align="left" rowspan="1" colspan="1">131.5Â±18.6</td>
                        <td align="left" rowspan="1" colspan="1">116.5Â±27.3</td>
                        <td align="left" rowspan="1" colspan="1">0.05</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Valsalva IIe MAP</td>
                        <td align="left" rowspan="1" colspan="1">110.6Â±17.6</td>
                        <td align="left" rowspan="1" colspan="1">93.3Â±17.0</td>
                        <td align="left" rowspan="1" colspan="1">0.03</td>
                        <td align="left" rowspan="1" colspan="1">94.5Â±16.6</td>
                        <td align="left" rowspan="1" colspan="1">91.5Â±24.3</td>
                        <td align="left" rowspan="1" colspan="1">0.63</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Valsalva IIi MAP</td>
                        <td align="left" rowspan="1" colspan="1">131.6Â±25.4</td>
                        <td align="left" rowspan="1" colspan="1">109.8Â±30.8</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                        <td align="left" rowspan="1" colspan="1">112.4Â±26.0</td>
                        <td align="left" rowspan="1" colspan="1">115.1Â±28.5</td>
                        <td align="left" rowspan="1" colspan="1">0.82</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Valsalva III MAP</td>
                        <td align="left" rowspan="1" colspan="1">107.0Â±26.4</td>
                        <td align="left" rowspan="1" colspan="1">89.3Â±28.2</td>
                        <td align="left" rowspan="1" colspan="1">0.12</td>
                        <td align="left" rowspan="1" colspan="1">89.4Â±27.0</td>
                        <td align="left" rowspan="1" colspan="1">81.5Â±26.6</td>
                        <td align="left" rowspan="1" colspan="1">0.38</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Valsalva IV MAP</td>
                        <td align="left" rowspan="1" colspan="1">146.2Â±27.0</td>
                        <td align="left" rowspan="1" colspan="1">127.5Â±26.5</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                        <td align="left" rowspan="1" colspan="1">130.6Â±26.3</td>
                        <td align="left" rowspan="1" colspan="1">115.6Â±30.5</td>
                        <td align="left" rowspan="1" colspan="1">0.11</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jah33236-note-0005">
                      <p>Significance is shown between time points. DBP indicates diastolic blood pressure; HR, heart rate; MAP, mean arterial pressure; SBP, systolic blood pressure.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>With the Valsalva maneuver, the treatment group showed a significant reduction in MAP during phase I (11.5Â±17.4Â mmÂ Hg, <italic>P</italic>&lt;0.05), phase IIe (15.4Â±19.3Â mmÂ Hg, <italic>P</italic>&lt;0.05), phase IIi (19.1Â±25.2Â mmÂ Hg, <italic>P</italic>&lt;0.05), and phase IV (17.8Â±24.1Â mmÂ Hg, <italic>P</italic>&lt;0.05) at 6âmonth followâup compared with baseline. In subjects who underwent the sham procedure, a significant reduction was only observed in MAP during phase I (10.6Â±29.6Â mmÂ Hg, <italic>P</italic>=0.05).</p>
              </sec>
            </sec>
            <sec id="jah33236-sec-0025">
              <title>Discussion</title>
              <p>In this substudy of the WAVE IV trial, we demonstrate substantial and significant reduction in office BP compared with baseline in both treatment and sham groups, and reduction in ambulatory BP that was statistically significant in the sham group. Reasons for the failure of external ultrasound RDN to provide a significant reduction in BP over and above sham therapy have been previously described.<xref rid="jah33236-bib-0017" ref-type="ref">17</xref> It would be reasonable to propose that this novel technology actually did not achieve renal denervation based upon the BP response alone, but 2 lines of evidence support the hypothesis that renal nerve ablation did occur following active therapy in our study.</p>
              <p>First, the decrease in HR in the RDN group both at rest and during postural maneuvers was significant, whereas it was not in the sham group. This is of interest because RDN has previously been shown to reduce HR.<xref rid="jah33236-bib-0019" ref-type="ref">19</xref> It is possible that HR changes are related to increased baroreflex sensitivity postâRDN, and it has been previously demonstrated that impaired baroreflex sensitivity predicts response to catheterâbased RDN.<xref rid="jah33236-bib-0020" ref-type="ref">20</xref> In our study, however, there were no significant withinâgroup changes in baroreflex sensitivity or resting cardiac vagal tone from baseline compared with 6Â months (TableÂ <xref rid="jah33236-sup-0001" ref-type="supplementary-material">S1</xref>). Together with the significant reduction in MAP during the sit up in the RDN group, this suggests that the observed HR changes following RDN might be attributable to a reduction in global sympathetic tone.</p>
              <p>Second, the changes in autonomic function in the treatment group, and in particular reduction in MAP, noted during the Valsalva maneuver following RDN in our opinion suggests a successful renal nerve ablation procedure. The Valsalva maneuver is a commonly used physiological tool to assess autonomic function. The baroreceptorâmediated tachycardia in phase II and bradycardia in phase IV are used as indices of cardiovagal integrity.<xref rid="jah33236-bib-0021" ref-type="ref">21</xref> Blood pressure recovery in late phase II and hypertensive response in phase IV are often used as indices of baroreceptorâmediated sympathetic integrity.<xref rid="jah33236-bib-0022" ref-type="ref">22</xref>
</p>
              <p>The sympathetic efferent nerves supply the capsulated organs in the splanchnic bed, namely, liver, spleen, and kidneys. Sympathetic stimulation plays an important role in Î±â1âadrenergicâmediated contraction of these capsular organs. This drives splanchnic autotransfusionâequivalent to a blood volume reservoirâin the splanchnic vascular bed, which in turn increases sympatheticâdriven venous return to the heart whenever it is below a regulated level.<xref rid="jah33236-bib-0016" ref-type="ref">16</xref>
</p>
              <p>The mechanism of BP changes during the Valsalva maneuver is described elsewhere.<xref rid="jah33236-bib-0023" ref-type="ref">23</xref> There is evidence of volume receptors and/or baroreceptor modulation of the volumes of encapsulated organs in the splanchnic vascular bed through sympatheticâmediated constriction during reduced venous return.<xref rid="jah33236-bib-0024" ref-type="ref">24</xref> There is also evidence of left atrial volume receptors stimulated by atrial dilation that modulates renal sympathetic activity in animal studies.<xref rid="jah33236-bib-0025" ref-type="ref">25</xref> Since there is evidence of plasma volumeârelated BP responses to the Valsalva maneuver in humans, the regulatory mechanism is the same as observed in animal studies.<xref rid="jah33236-bib-0026" ref-type="ref">26</xref> There are in addition studies of BP changes in humans during the Valsalva maneuver after pharmacological blockade of Î±â1â and Î²â1âadrenergic receptors and other functions of the autonomic nervous system.<xref rid="jah33236-bib-0023" ref-type="ref">23</xref> It is therefore clear that the late phase II, marked by the recovery of BP during active positive intrathoracic pressure, is caused by volume receptorâmediated increase in sympathetic outflow leading to Î±â1âadrenergicâmediated vasoconstriction resulting in splanchnic autotransfusion as a consequence of the contraction of capsulated organs such as the liver, spleen, and kidneys. This is accompanied by cardiac sympathetic stimulation and tachycardia.</p>
              <p>In this study, we have shown attenuation of this Î±â1âadrenergicâmediated BP recovery in late phase II and phase IV of the Valsalva maneuver in the RDN group that is not seen in the sham group and has never been previously demonstrated. This shows reduction in greater splanchnic nerve sympathetic activity, because there is no change in total blood volume or BP. Of note, in animal models, total SNS tone in the body is directly correlated with MAP within a certain BP range.<xref rid="jah33236-bib-0027" ref-type="ref">27</xref> In this cohort of subjects, the baseline MAP in the 2 subgroups was very similar. There was no significant change in resting MAP in the RDN group or sham group postprocedure, suggesting no change in the total SNS activity with RDN.</p>
              <p>Previous studies using RDN to lower BP have quantified change in SNS activity in the body with changes in muscle sympathetic nerve activity and norepinephrine spillover, but even these techniques have their limitations and are not ideal measures for assessing procedural success.<xref rid="jah33236-bib-0028" ref-type="ref">28</xref> Measuring peripheral sympathetic drive by microneurography is invasive and technically demanding for both operator and the patient. In addition, the information provided is limited to regional sympathetic neural activity. Given the heterogeneity of systemâspecific sympathetic innervations, muscle sympathetic nerve activity may not necessarily reflect changes in global sympathetic tone. Muscle sympathetic nerve activity measurements can be affected by observer variability by 9% and have inherent bias against low levels of sympathetic activity.<xref rid="jah33236-bib-0028" ref-type="ref">28</xref> Norepinephrine spillover is an indirect index of sympathetic neural activity and is influenced by regional differences in sympathetic outflow to different vascular beds. Also, different environmental stress triggers lead to variable regional sympathetic outflow and hence, influences the levels of norepinephrine spillover. Newer methods of assessing sympathetic innervation in the context of RDN include the ConfidenHT mapping system (<ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">http://ClinicalTrials.gov</ext-link> Identifier: NCT02777216) and direct neural monitoring from Autonomix Medical (<ext-link ext-link-type="uri" xlink:href="http://www.autonomixmed.com">http://www.autonomixmed.com</ext-link>), which are currently under evaluation and remain to be proven with no published data to date.</p>
              <p>Although the WAVE IV study was terminated early, it is important to note that a sizeable sham effect in device therapy of hypertension studies is well recognized and clearly this needs to be explored further.<xref rid="jah33236-bib-0002" ref-type="ref">2</xref>, <xref rid="jah33236-bib-0029" ref-type="ref">29</xref> It may be considered that this finding acts as a warning that interventional therapies have not failed as antihypertensive strategies if they demonstrate significant absoluteÂ ambulatory BP reduction (&gt;6Â mmÂ Hg) compared with baseline, but they may not necessarily succeed against sham.<xref rid="jah33236-bib-0030" ref-type="ref">30</xref> Sham effects can persist up to 6Â months postprocedure as seen in the WAVE IV and other studies. In our substudy, we demonstrate that the commonly used BPâlowering end point is just 1 of several cardiovascular outcomes of RDN, as we have demonstrated effective renal nerve ablation following RDN with changes in both HR and in the Valsalva maneuver that were not seen with sham.</p>
              <p>Our findings should be tested a priori in a larger randomized controlled study before making strong recommendations about how to use these markers to document success, and may furthermore lead to improved patient selection for RDN therapies because those subjects who demonstrate exaggerated restoration of MAP (&gt;15Â mmÂ Hg above baseline) in phase 2i of Valsalva, indicative of raised baseline splanchnic sympathetic tone, are likely to exhibit an increased response to renal nerve ablation. Given that our method is noninvasive, this could be thereafter adopted at scale in addition to its use as a marker of procedural success.</p>
              <p>Renal denervation has moved some way forward since it was first demonstrated to be effective in openâlabel studies almost a decade ago. Since then there have been considerable advances in our understanding of renal neural microanatomy and how best to achieve effective endovascular renal SNS ablation. Now that a recent proof of concept study has demonstrated convincingly that RDN is effective at lowering BP in moderate hypertension compared with sham, it has become more important than ever before to demonstrate procedural success.<xref rid="jah33236-bib-0031" ref-type="ref">31</xref> Our approach using the Valsalva maneuver is relatively straightforward and reproducible and illustrates convincingly that RDN can attenuate BP responses to the Valsalva maneuver, which was not the case with a sham procedure. Just as importantly, we show that despite having no effect on renal SNS innervation, a sham procedure has profound effects on office and ambulatory BP, which has significant implications for clinical trial designs of the future.</p>
              <sec id="jah33236-sec-0026">
                <title>Limitations</title>
                <p>Our study has its limitations. It was undertaken as a substudy of the WAVE IV trial but the study assessments (including autonomic function tests) and the analysis was done in a blinded fashion to exclude bias. Our sample size was small and the study was not powered to assess changes in autonomic function tests between the groups. Although preâexisting medications might have influenced the results (particularly in the case of drugs interfering with SNS activity such as diuretics and Î²âblockers), they were evenly matched between the 2 groups and it would have been unethical to alter antihypertensive medications in order to do autonomic assessments. Importantly, in the WAVE IV study, overall adherence with medications was demonstrated to be â80% for both groups at baseline and did not change significantly at the 6âmonth followâup visit, suggesting that medication changes were not responsible for the changes in BP, HR, or Valsalva parameters in either group.</p>
              </sec>
            </sec>
            <sec id="jah33236-sec-0027">
              <title>Author Contributions</title>
              <p>Lobo was the principal investigator of this trial. Saxena and Shour wrote this report and all other authors contributed to data collection and/or revisions to the manuscript.</p>
            </sec>
            <sec id="jah33236-sec-0029">
              <title>Sources of Funding</title>
              <p>The WAVE IV study was funded by Kona Medical. Autonomic testing (equipment and personnel) were funded by Barts Charity. M. Saxena, MDL, DJC, VK, AG, AZ, AB and JP are supported in part by Barts NIHR BRC and this work forms part of the research portfolio for the National Institute for Health Research Barts Biomedical Research Centre.</p>
            </sec>
            <sec id="jah33236-sec-0030">
              <title>Disclosures</title>
              <p>Dr Lobo has received a modest research grant from Medtronic, modest honoraria from Cardiosonic, CVRx, Kona Medical and St. Jude Medical, and modest fees for consulting and advisory board participation from ROX Medical. Professor Dr med. Schmieder has received a modest research grant and modest speaker bureau fees from Kona Medical, Medtronic, and Recor. The remaining authors have no disclosures to report.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="jah33236-sup-0001">
                <caption>
                  <p><bold>Data S1.</bold> Supplemental Methods.</p>
                  <p><bold>TableÂ S1.</bold> WithinâGroup Changes in Resting Cardiac Vagal Tone (CVT) and Baroreflex Sensitivity (BRS) Between Baseline and 6Â Months Postprocedure</p>
                </caption>
                <media xlink:href="JAH3-7-e009151-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="jah33236-sec-0028">
              <title>Acknowledgments</title>
              <p>Dr Omar Dawood and Dr Michael Gertner (both Kona Medical employees) organized the WAVE IV study and the treatment procedures at Barts Health NHS Trust.</p>
            </ack>
            <ref-list content-type="cited-references" id="jah33236-bibl-0001">
              <title>References</title>
              <ref id="jah33236-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0001"><string-name><surname>Lobo</surname><given-names>MD</given-names></string-name>, <string-name><surname>Sobotka</surname><given-names>PA</given-names></string-name>, <string-name><surname>Pathak</surname><given-names>A</given-names></string-name>. <article-title>Interventional procedures and future drug therapy for hypertension</article-title>. <source xml:lang="en">Eur Heart J</source>. <year>2017</year>;<volume>38</volume>:<fpage>1101</fpage>â<lpage>1111</lpage>.<pub-id pub-id-type="pmid">27406184</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0002"><string-name><surname>Bisognano</surname><given-names>JD</given-names></string-name>, <string-name><surname>Bakris</surname><given-names>G</given-names></string-name>, <string-name><surname>Nadim</surname><given-names>MK</given-names></string-name>, <string-name><surname>Sanchez</surname><given-names>L</given-names></string-name>, <string-name><surname>Kroon</surname><given-names>AA</given-names></string-name>, <string-name><surname>Schafer</surname><given-names>J</given-names></string-name>, <string-name><surname>de Leeuw</surname><given-names>PW</given-names></string-name>, <string-name><surname>Sica</surname><given-names>DA</given-names></string-name>. <article-title>Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the doubleâblind, randomized, placeboâcontrolled rheos pivotal trial</article-title>. <source xml:lang="en">J Am Coll Cardiol</source>. <year>2011</year>;<volume>58</volume>:<fpage>765</fpage>â<lpage>773</lpage>.<pub-id pub-id-type="pmid">21816315</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0003"><string-name><surname>Esler</surname><given-names>MD</given-names></string-name>, <string-name><surname>Sobotka</surname><given-names>PA</given-names></string-name>, <string-name><surname>Schlaich</surname><given-names>MP</given-names></string-name>, <string-name><surname>Krum</surname><given-names>H</given-names></string-name>, <string-name><surname>Schmieder</surname><given-names>RE</given-names></string-name>, <string-name><surname>BÃ¶hm</surname><given-names>M</given-names></string-name>; <collab collab-type="authors">Symplicity HTNâ2 Investigators</collab>
. <article-title>Renal sympathetic denervation for treatment of drugâresistant hypertension: oneâyear results from the symplicity HTNâ2 randomized, controlled trial</article-title>. <source xml:lang="en">Circulation</source>. <year>2012</year>;<volume>126</volume>:<fpage>2976</fpage>â<lpage>2982</lpage>.<pub-id pub-id-type="pmid">23248063</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0004"><string-name><surname>Krum</surname><given-names>H</given-names></string-name>, <string-name><surname>Schlaich</surname><given-names>M</given-names></string-name>, <string-name><surname>Whitbourn</surname><given-names>R</given-names></string-name>, <string-name><surname>Sobotka</surname><given-names>PA</given-names></string-name>, <string-name><surname>Sadowski</surname><given-names>J</given-names></string-name>, <string-name><surname>Bartus</surname><given-names>K</given-names></string-name>, <string-name><surname>Kapelak</surname><given-names>B</given-names></string-name>, <string-name><surname>Walton</surname><given-names>A</given-names></string-name>, <string-name><surname>Sievert</surname><given-names>H</given-names></string-name>, <string-name><surname>Thambar</surname><given-names>S</given-names></string-name>, <string-name><surname>Abraham</surname><given-names>WT</given-names></string-name>, <string-name><surname>Esler</surname><given-names>M</given-names></string-name>. <article-title>Catheterâbased renal sympathetic denervation for resistant hypertension: a multicentre safety and proofâofâprinciple cohort study</article-title>. <source xml:lang="en">Lancet</source>. <year>2009</year>;<volume>373</volume>:<fpage>1275</fpage>â<lpage>1281</lpage>.<pub-id pub-id-type="pmid">19332353</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0005"><string-name><surname>Lobo</surname><given-names>MD</given-names></string-name>, <string-name><surname>Sobotka</surname><given-names>PA</given-names></string-name>, <string-name><surname>Stanton</surname><given-names>A</given-names></string-name>, <string-name><surname>Cockcroft</surname><given-names>JR</given-names></string-name>, <string-name><surname>Sulke</surname><given-names>N</given-names></string-name>, <string-name><surname>Dolan</surname><given-names>E</given-names></string-name>, <string-name><surname>van der Giet</surname><given-names>M</given-names></string-name>, <string-name><surname>Hoyer</surname><given-names>J</given-names></string-name>, <string-name><surname>Furniss</surname><given-names>SS</given-names></string-name>, <string-name><surname>Foran</surname><given-names>JP</given-names></string-name>, <string-name><surname>Witkowski</surname><given-names>A</given-names></string-name>, <string-name><surname>Januszewicz</surname><given-names>A</given-names></string-name>, <string-name><surname>Schoors</surname><given-names>D</given-names></string-name>, <string-name><surname>Tsioufis</surname><given-names>K</given-names></string-name>, <string-name><surname>Rensing</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Scott</surname><given-names>B</given-names></string-name>, <string-name><surname>Ng</surname><given-names>GA</given-names></string-name>, <string-name><surname>Ott</surname><given-names>C</given-names></string-name>, <string-name><surname>Schmieder</surname><given-names>RE</given-names></string-name>; <collab collab-type="authors">ROX CONTROL HTN Investigators</collab>
. <article-title>Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial</article-title>. <source xml:lang="en">Lancet</source>. <year>2015</year>;<volume>385</volume>:<fpage>1634</fpage>â<lpage>1641</lpage>.<pub-id pub-id-type="pmid">25620016</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0006"><string-name><surname>Scheffers</surname><given-names>IJ</given-names></string-name>, <string-name><surname>Kroon</surname><given-names>AA</given-names></string-name>, <string-name><surname>Schmidli</surname><given-names>J</given-names></string-name>, <string-name><surname>Jordan</surname><given-names>J</given-names></string-name>, <string-name><surname>Tordoir</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Mohaupt</surname><given-names>MG</given-names></string-name>, <string-name><surname>Luft</surname><given-names>FC</given-names></string-name>, <string-name><surname>Haller</surname><given-names>H</given-names></string-name>, <string-name><surname>Menne</surname><given-names>J</given-names></string-name>, <string-name><surname>Engeli</surname><given-names>S</given-names></string-name>, <string-name><surname>Ceral</surname><given-names>J</given-names></string-name>, <string-name><surname>Eckert</surname><given-names>S</given-names></string-name>, <string-name><surname>Erglis</surname><given-names>A</given-names></string-name>, <string-name><surname>Narkiewicz</surname><given-names>K</given-names></string-name>, <string-name><surname>Philipp</surname><given-names>T</given-names></string-name>, <string-name><surname>de Leeuw</surname><given-names>PW</given-names></string-name>. <article-title>Novel baroreflex activation therapy in resistant hypertension: results of a European multiâcenter feasibility study</article-title>. <source xml:lang="en">J Am Coll Cardiol</source>. <year>2010</year>;<volume>56</volume>:<fpage>1254</fpage>â<lpage>1258</lpage>.<pub-id pub-id-type="pmid">20883933</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0007"><string-name><surname>Schlaich</surname><given-names>MP</given-names></string-name>, <string-name><surname>Sobotka</surname><given-names>PA</given-names></string-name>, <string-name><surname>Krum</surname><given-names>H</given-names></string-name>, <string-name><surname>Lambert</surname><given-names>E</given-names></string-name>, <string-name><surname>Esler</surname><given-names>MD</given-names></string-name>. <article-title>Renal sympatheticânerve ablation for uncontrolled hypertension</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2009</year>;<volume>361</volume>:<fpage>932</fpage>â<lpage>934</lpage>.<pub-id pub-id-type="pmid">19710497</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0008"><string-name><surname>Allen</surname><given-names>TR</given-names></string-name>. <article-title>Current status of lumbar sympathectomy</article-title>. <source xml:lang="en">Am Surg</source>. <year>1976</year>;<volume>42</volume>:<fpage>89</fpage>â<lpage>91</lpage>.<pub-id pub-id-type="pmid">1108724</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0009"><string-name><surname>DiBona</surname><given-names>GF</given-names></string-name>. <article-title>Neural control of the kidney: past, present, and future</article-title>. <source xml:lang="en">Hypertension</source>. <year>2003</year>;<volume>41</volume>:<fpage>621</fpage>â<lpage>624</lpage>.<pub-id pub-id-type="pmid">12623969</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0010"><string-name><surname>Mahfoud</surname><given-names>F</given-names></string-name>, <string-name><surname>Bhatt</surname><given-names>DL</given-names></string-name>. <article-title>Catheterâbased renal denervation: the black box procedure</article-title>. <source xml:lang="en">JACC Cardiovasc Interv</source>. <year>2013</year>;<volume>6</volume>:<fpage>1092</fpage>â<lpage>1094</lpage>.<pub-id pub-id-type="pmid">24156969</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0011"><string-name><surname>Sakakura</surname><given-names>K</given-names></string-name>, <string-name><surname>Ladich</surname><given-names>E</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>Q</given-names></string-name>, <string-name><surname>Otsuka</surname><given-names>F</given-names></string-name>, <string-name><surname>Yahagi</surname><given-names>K</given-names></string-name>, <string-name><surname>Fowler</surname><given-names>DR</given-names></string-name>, <string-name><surname>Kolodgie</surname><given-names>FD</given-names></string-name>, <string-name><surname>Virmani</surname><given-names>R</given-names></string-name>, <string-name><surname>Joner</surname><given-names>M</given-names></string-name>. <article-title>Anatomic assessment of sympathetic periâarterial renal nerves in man</article-title>. <source xml:lang="en">J Am Coll Cardiol</source>. <year>2014</year>;<volume>64</volume>:<fpage>635</fpage>â<lpage>643</lpage>.<pub-id pub-id-type="pmid">25125292</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0012"><string-name><surname>Esler</surname><given-names>M</given-names></string-name>, <string-name><surname>Jennings</surname><given-names>G</given-names></string-name>, <string-name><surname>Korner</surname><given-names>P</given-names></string-name>, <string-name><surname>Willett</surname><given-names>I</given-names></string-name>, <string-name><surname>Dudley</surname><given-names>F</given-names></string-name>, <string-name><surname>Hasking</surname><given-names>G</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>W</given-names></string-name>, <string-name><surname>Lambert</surname><given-names>G</given-names></string-name>. <article-title>Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover</article-title>. <source xml:lang="en">Hypertension</source>. <year>1988</year>;<volume>11</volume>:<fpage>3</fpage>â<lpage>20</lpage>.<pub-id pub-id-type="pmid">2828236</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0013"><string-name><surname>Hering</surname><given-names>D</given-names></string-name>, <string-name><surname>Lambert</surname><given-names>EA</given-names></string-name>, <string-name><surname>Marusic</surname><given-names>P</given-names></string-name>, <string-name><surname>Walton</surname><given-names>AS</given-names></string-name>. <article-title>Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension</article-title>. <source xml:lang="en">Hypertension</source>. <year>2013</year>;<volume>61</volume>:<fpage>457</fpage>â<lpage>464</lpage>.<pub-id pub-id-type="pmid">23172929</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0014"><string-name><surname>Vink</surname><given-names>EE</given-names></string-name>, <string-name><surname>Verloop</surname><given-names>WL</given-names></string-name>, <string-name><surname>Siddiqi</surname><given-names>L</given-names></string-name>, <string-name><surname>van Schelven</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Liam Oey</surname><given-names>P</given-names></string-name>, <string-name><surname>Blankestijn</surname><given-names>PJ</given-names></string-name>. <article-title>The effect of percutaneous renal denervation on muscle sympathetic nerve activity in hypertensive patients</article-title>. <source xml:lang="en">Int J Cardiol</source>. <year>2014</year>;<volume>176</volume>:<fpage>8</fpage>â<lpage>12</lpage>.<pub-id pub-id-type="pmid">25027168</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0015"><string-name><surname>de Jong</surname><given-names>MR</given-names></string-name>, <string-name><surname>Adiyaman</surname><given-names>A</given-names></string-name>, <string-name><surname>Gal</surname><given-names>P</given-names></string-name>, <string-name><surname>Smit</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Delnoy</surname><given-names>PP</given-names></string-name>, <string-name><surname>Heeg</surname><given-names>JE</given-names></string-name>, <string-name><surname>van Hasselt</surname><given-names>BA</given-names></string-name>, <string-name><surname>Lau</surname><given-names>EO</given-names></string-name>, <string-name><surname>Persu</surname><given-names>A</given-names></string-name>, <string-name><surname>Staessen</surname><given-names>JA</given-names></string-name>, <string-name><surname>Ramdat Misier</surname><given-names>AR</given-names></string-name>, <string-name><surname>Steinberg</surname><given-names>JS</given-names></string-name>, <string-name><surname>Elvan</surname><given-names>A</given-names></string-name>. <article-title>Renal nerve stimulationâinduced blood pressure changes predict ambulatory blood pressure response after renal denervation</article-title>. <source xml:lang="en">Hypertension</source>. <year>2016</year>;<volume>68</volume>:<fpage>707</fpage>â<lpage>714</lpage>.<pub-id pub-id-type="pmid">27432864</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0016"><string-name><surname>Greenway</surname><given-names>CV</given-names></string-name>, <string-name><surname>Lister</surname><given-names>GE</given-names></string-name>. <article-title>Capacitance effects and blood reservoir function in the splanchnic vascular bed during nonâhypotensive haemorrhage and blood volume expansion in anaesthetized cats</article-title>. <source xml:lang="en">J Physiol</source>. <year>1974</year>;<volume>237</volume>:<fpage>279</fpage>â<lpage>294</lpage>.<pub-id pub-id-type="pmid">4825450</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0017"><string-name><surname>Schmieder</surname><given-names>RE</given-names></string-name>, <string-name><surname>Ott</surname><given-names>C</given-names></string-name>, <string-name><surname>Toennes</surname><given-names>SW</given-names></string-name>, <string-name><surname>Bramlage</surname><given-names>P</given-names></string-name>, <string-name><surname>Gertner</surname><given-names>M</given-names></string-name>, <string-name><surname>Dawood</surname><given-names>O</given-names></string-name>, <string-name><surname>Baumgart</surname><given-names>P</given-names></string-name>, <string-name><surname>O'Brien</surname><given-names>B</given-names></string-name>, <string-name><surname>Dasgupta</surname><given-names>I</given-names></string-name>, <string-name><surname>Nickenig</surname><given-names>G</given-names></string-name>, <string-name><surname>Ormiston</surname><given-names>J</given-names></string-name>, <string-name><surname>Saxena</surname><given-names>M</given-names></string-name>, <string-name><surname>Sharp</surname><given-names>ASP</given-names></string-name>, <string-name><surname>Sievert</surname><given-names>H</given-names></string-name>, <string-name><surname>Spinar</surname><given-names>J</given-names></string-name>, <string-name><surname>Starek</surname><given-names>Z</given-names></string-name>, <string-name><surname>Weil</surname><given-names>J</given-names></string-name>, <string-name><surname>Wenzel</surname><given-names>U</given-names></string-name>, <string-name><surname>Witkowski</surname><given-names>A</given-names></string-name>, <string-name><surname>Lobo</surname><given-names>MD</given-names></string-name>. <article-title>Phase ii randomized shamâcontrolled study of renal denervation for individuals with uncontrolled hypertensionâWAVE IV</article-title>. <source xml:lang="en">J Hypertens</source>. <year>2018</year>;<volume>36</volume>:<fpage>680</fpage>â<lpage>689</lpage>.<pub-id pub-id-type="pmid">29035942</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0018"><string-name><surname>Bogert</surname><given-names>LW</given-names></string-name>, <string-name><surname>van Lieshout</surname><given-names>JJ</given-names></string-name>. <article-title>Nonâinvasive pulsatile arterial pressure and stroke volume changes from the human finger</article-title>. <source xml:lang="en">Exp Physiol</source>. <year>2005</year>;<volume>90</volume>:<fpage>437</fpage>â<lpage>446</lpage>.<pub-id pub-id-type="pmid">15802289</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0019"><string-name><surname>Tsioufis</surname><given-names>C</given-names></string-name>, <string-name><surname>Papademetriou</surname><given-names>V</given-names></string-name>, <string-name><surname>Tsiachris</surname><given-names>D</given-names></string-name>, <string-name><surname>Dimitriadis</surname><given-names>K</given-names></string-name>, <string-name><surname>Kasiakogias</surname><given-names>A</given-names></string-name>, <string-name><surname>Kordalis</surname><given-names>A</given-names></string-name>, <string-name><surname>Antonakis</surname><given-names>V</given-names></string-name>, <string-name><surname>Kefala</surname><given-names>A</given-names></string-name>, <string-name><surname>Thomopoulos</surname><given-names>C</given-names></string-name>, <string-name><surname>Kallikazaros</surname><given-names>I</given-names></string-name>, <string-name><surname>Lau</surname><given-names>EO</given-names></string-name>, <string-name><surname>Stefanadis</surname><given-names>C</given-names></string-name>. <article-title>Drugâresistant hypertensive patients responding to multielectrode renal denervation exhibit improved heart rate dynamics and reduced arrhythmia burden</article-title>. <source xml:lang="en">J Hum Hypertens</source>. <year>2014</year>;<volume>28</volume>:<fpage>587</fpage>â<lpage>593</lpage>.<pub-id pub-id-type="pmid">24621623</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0020"><string-name><surname>Zuern</surname><given-names>CS</given-names></string-name>, <string-name><surname>Eick</surname><given-names>C</given-names></string-name>, <string-name><surname>Rizas</surname><given-names>KD</given-names></string-name>, <string-name><surname>Bauer</surname><given-names>S</given-names></string-name>, <string-name><surname>Langer</surname><given-names>H</given-names></string-name>, <string-name><surname>Gawaz</surname><given-names>M</given-names></string-name>, <string-name><surname>Bauer</surname><given-names>A</given-names></string-name>. <article-title>Impaired cardiac baroreflex sensitivity predicts response to renal sympathetic denervation in patients with resistant hypertension</article-title>. <source xml:lang="en">J Am Coll Cardiol</source>. <year>2013</year>;<volume>62</volume>:<fpage>2124</fpage>â<lpage>2130</lpage>.<pub-id pub-id-type="pmid">23973686</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0021"><string-name><surname>Nishimura</surname><given-names>RA</given-names></string-name>, <string-name><surname>Tajik</surname><given-names>AJ</given-names></string-name>. <article-title>The Valsalva maneuver and response revisited</article-title>. <source xml:lang="en">Mayo Clin Proc</source>. <year>1986</year>;<volume>61</volume>:<fpage>211</fpage>â<lpage>217</lpage>.<pub-id pub-id-type="pmid">3511334</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0022"><string-name><surname>Goldstein</surname><given-names>DS</given-names></string-name>, <string-name><surname>Holmes</surname><given-names>C</given-names></string-name>, <string-name><surname>Li</surname><given-names>ST</given-names></string-name>, <string-name><surname>Bruce</surname><given-names>S</given-names></string-name>, <string-name><surname>Metman</surname><given-names>LV</given-names></string-name>, <string-name><surname>Cannon</surname><given-names>RO</given-names><suffix>III</suffix></string-name>. <article-title>Cardiac sympathetic denervation in Parkinson disease</article-title>. <source xml:lang="en">Ann Intern Med</source>. <year>2000</year>;<volume>133</volume>:<fpage>338</fpage>â<lpage>347</lpage>.<pub-id pub-id-type="pmid">10979878</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0023"><string-name><surname>Sandroni</surname><given-names>P</given-names></string-name>, <string-name><surname>Benarroch</surname><given-names>EE</given-names></string-name>, <string-name><surname>Low</surname><given-names>PA</given-names></string-name>. <article-title>Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure</article-title>. <source xml:lang="en">J Appl Physiol</source>. <year>1991</year>;<volume>71</volume>:<fpage>1563</fpage>â<lpage>1567</lpage>.<pub-id pub-id-type="pmid">1757382</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0024"><string-name><surname>Risoe</surname><given-names>C</given-names></string-name>, <string-name><surname>Tan</surname><given-names>W</given-names></string-name>, <string-name><surname>Smiseth</surname><given-names>OA</given-names></string-name>. <article-title>Effect of carotid sinus baroreceptor reflex on hepatic and splenic vascular capacitance in vagotomized dogs</article-title>. <source xml:lang="en">Am J Physiol</source>. <year>1994</year>;<volume>266</volume>:<fpage>H1528</fpage>â<lpage>H1533</lpage>.<pub-id pub-id-type="pmid">8184930</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0025"><string-name><surname>Zucker</surname><given-names>IH</given-names></string-name>, <string-name><surname>Gorman</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Cornish</surname><given-names>KG</given-names></string-name>, <string-name><surname>Lang</surname><given-names>M</given-names></string-name>. <article-title>Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload</article-title>. <source xml:lang="en">Cardiovasc Res</source>. <year>1985</year>;<volume>19</volume>:<fpage>411</fpage>â<lpage>418</lpage>.<pub-id pub-id-type="pmid">4016817</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0026"><string-name><surname>FritschâYelle</surname><given-names>JM</given-names></string-name>, <string-name><surname>Convertino</surname><given-names>VA</given-names></string-name>, <string-name><surname>Schlegel</surname><given-names>TT</given-names></string-name>. <article-title>Acute manipulations of plasma volume alter arterial pressure responses during valsalva maneuvers</article-title>. <source xml:lang="en">J Appl Physiol</source>. <year>1999</year>;<volume>86</volume>:<fpage>1852</fpage>â<lpage>1857</lpage>.<pub-id pub-id-type="pmid">10368349</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0027"><string-name><surname>Sun</surname><given-names>MK</given-names></string-name>, <string-name><surname>Guyenet</surname><given-names>PG</given-names></string-name>. <article-title>Medullospinal sympathoexcitatory neurons in normotensive and spontaneously hypertensive rats</article-title>. <source xml:lang="en">Am J Physiol</source>. <year>1986</year>;<volume>250</volume>:<fpage>R910</fpage>â<lpage>R917</lpage>.<pub-id pub-id-type="pmid">3706576</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0028"><string-name><surname>Halliwill</surname><given-names>JR</given-names></string-name>. <article-title>Segregated signal averaging of sympathetic baroreflex responses in humans</article-title>. <source xml:lang="en">J Appl Physiol</source>. <year>2000</year>;<volume>88</volume>:<fpage>767</fpage>â<lpage>773</lpage>.<pub-id pub-id-type="pmid">10658049</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0029"><string-name><surname>Bhatt</surname><given-names>DL</given-names></string-name>, <string-name><surname>Kandzari</surname><given-names>DE</given-names></string-name>, <string-name><surname>O'Neill</surname><given-names>WW</given-names></string-name>, <string-name><surname>D'Agostino</surname><given-names>R</given-names></string-name>, <string-name><surname>Flack</surname><given-names>JM</given-names></string-name>, <string-name><surname>Katzen</surname><given-names>BT</given-names></string-name>, <string-name><surname>Leon</surname><given-names>MB</given-names></string-name>, <string-name><surname>Liu</surname><given-names>M</given-names></string-name>, <string-name><surname>Mauri</surname><given-names>L</given-names></string-name>, <string-name><surname>Negoita</surname><given-names>M</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>SA</given-names></string-name>, <string-name><surname>Oparil</surname><given-names>S</given-names></string-name>, <string-name><surname>RochaâSingh</surname><given-names>K</given-names></string-name>, <string-name><surname>Townsend</surname><given-names>RR</given-names></string-name>, <string-name><surname>Bakris</surname><given-names>GL</given-names></string-name>; <collab collab-type="authors">SYMPLICITY HTNâ3 Investigators</collab>
. <article-title>A controlled trial of renal denervation for resistant hypertension</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2014</year>;<volume>370</volume>:<fpage>1393</fpage>â<lpage>1401</lpage>.<pub-id pub-id-type="pmid">24678939</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0030"><string-name><surname>Mahfoud</surname><given-names>F</given-names></string-name>, <string-name><surname>Schmieder</surname><given-names>RE</given-names></string-name>, <string-name><surname>Azizi</surname><given-names>M</given-names></string-name>, <string-name><surname>Pathak</surname><given-names>A</given-names></string-name>, <string-name><surname>Sievert</surname><given-names>H</given-names></string-name>, <string-name><surname>Tsioufis</surname><given-names>C</given-names></string-name>, <string-name><surname>Zeller</surname><given-names>T</given-names></string-name>, <string-name><surname>Bertog</surname><given-names>S</given-names></string-name>, <string-name><surname>Blankestijn</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Bohm</surname><given-names>M</given-names></string-name>, <string-name><surname>Burnier</surname><given-names>M</given-names></string-name>, <string-name><surname>Chatellier</surname><given-names>G</given-names></string-name>, <string-name><surname>Durand Zaleski</surname><given-names>I</given-names></string-name>, <string-name><surname>Ewen</surname><given-names>S</given-names></string-name>, <string-name><surname>Grassi</surname><given-names>G</given-names></string-name>, <string-name><surname>Joner</surname><given-names>M</given-names></string-name>, <string-name><surname>Kjeldsen</surname><given-names>SE</given-names></string-name>, <string-name><surname>Lobo</surname><given-names>MD</given-names></string-name>, <string-name><surname>Lotan</surname><given-names>C</given-names></string-name>, <string-name><surname>Luscher</surname><given-names>TF</given-names></string-name>, <string-name><surname>Parati</surname><given-names>G</given-names></string-name>, <string-name><surname>Rossignol</surname><given-names>P</given-names></string-name>, <string-name><surname>Ruilope</surname><given-names>L</given-names></string-name>, <string-name><surname>Sharif</surname><given-names>F</given-names></string-name>, <string-name><surname>van Leeuwen</surname><given-names>E</given-names></string-name>, <string-name><surname>Volpe</surname><given-names>M</given-names></string-name>, <string-name><surname>Windecker</surname><given-names>S</given-names></string-name>, <string-name><surname>Witkowski</surname><given-names>A</given-names></string-name>, <string-name><surname>Wijns</surname><given-names>W</given-names></string-name>. <article-title>Proceedings from the 2nd European Clinical Consensus Conference for deviceâbased therapies for hypertension: state of the art and considerations for the future</article-title>. <source xml:lang="en">Eur Heart J</source>. <year>2017</year>;<volume>38</volume>:<fpage>3272</fpage>â<lpage>3281</lpage>.<pub-id pub-id-type="pmid">28475773</pub-id></mixed-citation>
              </ref>
              <ref id="jah33236-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jah33236-cit-0031"><string-name><surname>Townsend</surname><given-names>RR</given-names></string-name>, <string-name><surname>Mahfoud</surname><given-names>F</given-names></string-name>, <string-name><surname>Kandzari</surname><given-names>DE</given-names></string-name>, <string-name><surname>Kario</surname><given-names>K</given-names></string-name>, <string-name><surname>Pocock</surname><given-names>S</given-names></string-name>, <string-name><surname>Weber</surname><given-names>MA</given-names></string-name>, <string-name><surname>Ewen</surname><given-names>S</given-names></string-name>, <string-name><surname>Tsioufis</surname><given-names>K</given-names></string-name>, <string-name><surname>Tousoulis</surname><given-names>D</given-names></string-name>, <string-name><surname>Sharp</surname><given-names>ASP</given-names></string-name>, <string-name><surname>Watkinson</surname><given-names>AF</given-names></string-name>, <string-name><surname>Schmieder</surname><given-names>RE</given-names></string-name>, <string-name><surname>Schmid</surname><given-names>A</given-names></string-name>, <string-name><surname>Choi</surname><given-names>JW</given-names></string-name>, <string-name><surname>East</surname><given-names>C</given-names></string-name>, <string-name><surname>Walton</surname><given-names>A</given-names></string-name>, <string-name><surname>Hopper</surname><given-names>I</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>DL</given-names></string-name>, <string-name><surname>Wilensky</surname><given-names>R</given-names></string-name>, <string-name><surname>Lee</surname><given-names>DP</given-names></string-name>, <string-name><surname>Ma</surname><given-names>A</given-names></string-name>, <string-name><surname>Devireddy</surname><given-names>CM</given-names></string-name>, <string-name><surname>Lea</surname><given-names>JP</given-names></string-name>, <string-name><surname>Lurz</surname><given-names>PC</given-names></string-name>, <string-name><surname>Fengler</surname><given-names>K</given-names></string-name>, <string-name><surname>Davies</surname><given-names>J</given-names></string-name>, <string-name><surname>Chapman</surname><given-names>N</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>SA</given-names></string-name>, <string-name><surname>DeBruin</surname><given-names>V</given-names></string-name>, <string-name><surname>Fahy</surname><given-names>M</given-names></string-name>, <string-name><surname>Jones</surname><given-names>DE</given-names></string-name>, <string-name><surname>Rothman</surname><given-names>M</given-names></string-name>, <string-name><surname>Bohm</surname><given-names>M</given-names></string-name>; <collab collab-type="authors">SPYRAL HTNâOFF MED trial investigators</collab>
. <article-title>Catheterâbased renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTNâOFF MED): a randomised, shamâcontrolled, proofâofâconcept trial</article-title>. <source xml:lang="en">Lancet</source>. <year>2017</year>;<volume>390</volume>:<fpage>2160</fpage>â<lpage>2170</lpage>.<pub-id pub-id-type="pmid">28859944</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
